Dilution Watch — 16 November 2026
The week in ASX capital raises and dilution, from the filings themselves. Every figure comes from ASX announcements as published on DilutionLens. This edition covers Monday 9 to Friday 13 November, and it is the resources edition we promised.
One uranium producer took most of the money. Twenty-two companies announced new cash raises for about A$1.17B. Sixteen of them were resource companies, with A$677.7M between them, and uranium producer PDN alone took A$575M of that. The other fourteen resource raisers that named an amount disclosed A$102.7M. Outside resources, SSM raised A$475M to buy a company. Halts rose: 13 companies halted for a capital raise in five sessions, against 8 the week before and 23 the week before that.
The week's biggest resource raises
A holder left out of these placements keeps between 0.67% (Auric) and 0.87% (Paladin, Pacific Lime) of every 1% they held. Each line ends with that figure, counting shares still waiting for a vote.
- PDN — Paladin Energy is raising A$525M, underwritten, at A$7.80 (12 November): A$474M placed in Australia and C$50M in Canada. The price is “a 10.3% discount to the last close of A$8.70 on the ASX on 11 November 2026”. Holders can add up to A$50M through an SPP at the same price, opening 23 November. It last traded at A$7.17, below the placement. A 1% holder left out ends at about 0.87%. Dilution risk: Moderate.
- PLA — Pacific Lime and Cement placed A$50M at 36 cents (9 November), “a 5.3% discount to the last closing price and a 3.6% discount to the 5-day VWAP”. It used both mandates: 45,681,187 shares under 7.1 and 93,207,702 under 7.1A, the extra 10% holders approve each year. The same release has a term sheet for a convertible note from the US development bank DFC, converting at 42 cents. Its latest quarterly showed 0.46 quarters of funding before the raise. A 1% holder ends at about 0.87%. Dilution risk: Moderate.
- AWJ — Auric Mining, a gold developer, placed A$17M at 18.5 cents (12 November), with an SPP for up to A$3M at the same price. A$8.3M of the placement waits for a meeting in mid-December. The release states no discount; the SPP needs an ASX waiver because its price does not meet the usual SPP discount limit. Auric had A$33.0M of cash at the end of September. A 1% holder ends at about 0.67%. Dilution risk: Moderate.
- AMD — Arrow Minerals placed A$5.5M at 2 cents (12 November) after an option to buy the Pannawonica iron ore project. The release states no discount. It splits as 96,096,114 shares under 7.1 and 173,153,886 under 7.1A, with A$115,000 from directors waiting for a vote. A 1% holder ends at about 0.86%. Dilution risk: High.
Two smaller ones priced close to the market. SGA — Sarytogan Graphite opened a 1-for-4 entitlement offer for up to A$3.85M at 5.8 cents, “a discount of approximately 2% to the last closing price” and about 16% to the 10-day VWAP. CTN — Catalina Resources placed A$3.39M at 5.5 cents, “a 9.1% premium to the 15-trading-day” VWAP, alongside buying a Mid-West WA gold project. That placement uses “the Company's entire available placement capacity”.
Outside resources
SSM — Service Stream is raising A$475M at A$2.03 (9 November) to help buy Programmed: a A$219M placement and a A$256M 1-for-4.9 entitlement offer, both underwritten. That is a “7.7% discount to the last closing price of $2.20” and 5.7% below the price after the new shares. The new shares add about 37.8% to the register. A 1% holder who takes up the entitlement ends at about 0.87%; one who skips it, about 0.73%. The retail offer opens today and closes 27 November. Dilution risk: Minimal.
SET — Solaris Australian Equity Income Plus is offering a 1-for-3 entitlement and a placement at A$2.02, not underwritten. A$92.0M is the most it can raise if every share is taken, so it is left out of the week's total, as Gryphon's plan was last week.
The rest of the week. In resources: AA2, a gold company, about A$7.2M by placement. XRA A$5M in cash and shares. DME A$2M of convertible notes. FUL and BTE A$1.5M SPPs each. PXX A$1.45M. KNI about A$600,000. EDO A$350,000. IMI A$201,500. And MEL a renounceable entitlement offer. Outside resources: CX8 listed on 12 November after a A$12M float at 20 cents. DEL A$1.4M. IOV A$1M. WOA A$871,000. RBR A$600,000. The floats lining up next, from a tungsten developer on 26 November, are on the IPOs page.
Said before the raise
What management said about cash, and what came next. Two checked cases, one honest middle and one clean contrast. Interview quotes via TranscriptAgent; each links the video at the moment it was said.
- ASL — Andean Silver. Asked on 1 June 2025 whether it would have to raise, CEO Tim Laneyrie said: “our cash balance at the end of the quarter is sitting at about 20 million Australian currently. So we're sitting quite well to see through the rest of the year and into next year with the current cash that we have and any future raise will be guided by ... most of these large systems you would like to have a dozen rigs at any time to hit the targets ... we will adjust our plan and our capital raisings to suit the current phase of the project.” Then it raised A$30M at A$1.20 in July 2025, A$30M at A$1.85 plus a A$6M SPP in December, and A$40M at A$2.45 in September 2026: A$106M in 14 months. He said the raises would follow the drilling, and each priced above the last.
- LOT — Lotus Resources. On 20 February 2025, CEO Greg Bittar said the company was “not only funded through capex but funded through to cash flow, which we expect to be in early 2026”. Then a A$65M placement in September 2025, about A$76M by placement and SPP in February 2026, and in July 2026 a A$60.1M entitlement offer plus a A$35M convertible note: about A$200M of new shares in 17 months.
Last week's raisers, a week on
Fifteen of the 29 companies with a stated price that raised in the week of the last edition now trade below it. FXG, which placed at 12 cents, last traded at 9.3 cents. GHY, at 44 cents, is at 39 cents.
In resources, the middle raises as often as the bottom
Healthcare split cleanly by size last week; resources does not. Of 860 ASX resource companies, 70 are worth A$1B or more, and 13 of them raised cash in the last 12 months. Of the 174 worth A$100M to A$1B, 110 raised, about the same share as the 594 under A$100M, where 393 did. Of those small ones, 224 had less than two quarters of cash by their own latest quarterly report, and another 41 have no such estimate on record.
The four small ones with the least left at 30 September, by their own quarterly, and what each has done since:
- AS2 — Askari Metals: A$64,000 of funding, which its own report rounds to 0 quarters, plus A$445,000 of listed shares it can sell. Since then, shares issued under a settlement deed and a change of name to Highland Metals; no cash raise.
- MIO — Macarthur Minerals: A$14,000, 0.04 quarters. On 10 November a secured loan of up to A$1M at 14% a year for six months, with 5 million options. Its words: “We have elected to take on this loan rather than raise equity at current share prices”.
- RB6 — Rubix Resources: A$6,000, 0.05 quarters. Nothing announced since; its quarterly says it “will be required to raise further cash to funds its operations”.
- ATC — Altech Batteries: A$42,000, 0.07 quarters. Since then a signed agreement to sell land in Malaysia; the quarterly also counts on a A$418,000 R&D refund.
By commodity, the share that raised in 12 months runs from 30 of 38 lithium companies and 26 of 34 rare earth ones down to 185 of 307 gold, 15 of 26 uranium and 35 of 63 oil and gas. Copper sits at 67 of 102.
Vesting hurdles this week
EDO — El Dorado Goldfields issued 2 billion performance rights on 13 November, director rights its holders approved plus consultant rights under its incentive plan. The director rights approved at the meeting vest in classes as the company's market value reaches milestones from A$25 million up to A$450 million. After the issue, El Dorado has 5.6 billion performance rights on issue against 10.1 billion quoted shares.
New this week: tungsten and rare earth lists
Tungsten and rare earths now have their own lists, next to gold, copper, lithium, uranium, silver and oil and gas. Each shows project stage, cash runway, raises in the last 12 months and dilution risk, and the home page now links them under the search box.
The halt conveyor
Thirteen companies halted for a capital raise in five sessions, against 8 and 23 in the two weeks before. Ten had raised by Friday: AMD, AWJ, KNI, PDN, PXX, RBR, SET, SSM, WOA and XRA. AT4, M79 and MPK halted on Thursday and were due back today. MEL, still halted at the last edition, announced its entitlement offer this week. The halts page has today's list.
Thirty-five retail offers are open
Holders in 35 companies have a retail offer running or announced, up from 32 a week ago: 17 share purchase plans, 12 entitlement offers and 6 rights issues. Five came in this week: SPPs from PDN, AWJ, FUL and BTE, and SGA's entitlement offer. The oldest still listed, LMG's entitlement offer, is dated 17 September.
Placement capacity
The capacity page today lists 130 companies past 75% of their 15% allowance, 76 past 90%, and 13 that have used all of it, against 135, 80 and 14 a week ago. Of this week's raisers, XRA has used about 99% of its 15% placement capacity in 12 months.
Overhangs and runway among this week's raisers
Options, rights and convertibles already on issue are the dilution that comes after the raise. IMI's equal 111.4% of its register, EDO's 83.8% and CTN's 71.9%, none of them in the money. The thinnest runway before raising was RBR's, 0.17 quarters by its own latest quarterly, then BTE at 0.30 and PLA at 0.46. Every class expiring in the next 90 days is on the expiries page.
Dilution Watch is compiled from ASX announcements (Appendix filings, quarterly cash reports and raise notices) as published on DilutionLens. General information only, not financial advice; no view is expressed on any company's future actions or securities.